Study Information
Locations
Not Specified
Clinical Trial FAQs
Information for patients and study volunteers, including frequently asked questions.
Description
This study (in English: Men with Choices to Improve Well-being and Decrease Chronic Disease Risk) is a pragmatic, comparative effectiveness trial where obese Latino men will receive, by random assignment, the HOMBRE intervention or a minimal intensity intervention. Eligible Latino men (n=424) with a BMI >30 kg/m2 (≥27.5 kg/m2 if Asian descent) and ≥1 metabolic syndrome component will be enrolled, randomized to HOMBRE (intervention; n=212) or the minimal intensity intervention (control; n=212), and followed until 18 months, with passive monitoring of BMI through the EHR through 24 months.
A trained lifestyle coach will meet with HOMBRE (intervention) participants to facilitate an informed choice of delivery modalities: (1) Individual approach via videos, (2) Online virtual groups, or (3) In-person groups. All delivery modalities provide the same evidence-based curriculum and include self-monitoring and individualized feedback from the lifestyle coach.
Specific aims:
Aim 1: Compare the effectiveness of HOMBRE with a minimal intensity intervention for sustaining clinically significant weight loss at 18 months.
Aim 2: Compare the effectiveness of HOMBRE with a minimal intensity intervention for improving cardiometabolic risk factors, health behaviors, and psychosocial well-being at 18 months.
Aim 3: Compare the other attributes of RE-AIM (reach, adoption, implementation, and maintenance) within the two interventions to inform rapid dissemination and long-term sustainability.
Other co-investigators are Jun Ma, M.D., Ph.D., University of Illinois at Chicago; Steven Hooker, Ph.D., Arizona State University; Megan Lewis, Ph.D., RTI Internal; Patricia Zavella, Ph.D., University of California, Santa Cruz; and Elizabeth Venditti, Ph.D., University of Pittsburgh.
A trained lifestyle coach will meet with HOMBRE (intervention) participants to facilitate an informed choice of delivery modalities: (1) Individual approach via videos, (2) Online virtual groups, or (3) In-person groups. All delivery modalities provide the same evidence-based curriculum and include self-monitoring and individualized feedback from the lifestyle coach.
Specific aims:
Aim 1: Compare the effectiveness of HOMBRE with a minimal intensity intervention for sustaining clinically significant weight loss at 18 months.
Aim 2: Compare the effectiveness of HOMBRE with a minimal intensity intervention for improving cardiometabolic risk factors, health behaviors, and psychosocial well-being at 18 months.
Aim 3: Compare the other attributes of RE-AIM (reach, adoption, implementation, and maintenance) within the two interventions to inform rapid dissemination and long-term sustainability.
Other co-investigators are Jun Ma, M.D., Ph.D., University of Illinois at Chicago; Steven Hooker, Ph.D., Arizona State University; Megan Lewis, Ph.D., RTI Internal; Patricia Zavella, Ph.D., University of California, Santa Cruz; and Elizabeth Venditti, Ph.D., University of Pittsburgh.
Co-Investigator(s)
Kristen M.J. Azar, R.N., BSN, MSN/MPH
Funder
Patient-Centered Outcomes Research Institute (PCORI)
Related Studies
COVID-19 Impacts on Cancer Care Management, Patient Experience and Care Costs
Project goals: To understand impacts of COVID-19 on cancer care management (detection, diagnosis, treatment), pt-reported experience, and cancer care costs.
Investigators: Cheryl Stults, Ph.D., Su-Ying Liang, Ph.D., Monique de Bruin, M.D., MPH
Stupski Serious Illness Program Evaluation
Evaluate palliative care projects at seven healthcare organizations in the SF Bay Area.
Investigator: Sylvia Sudat, PhD
Impact of COVID-19 on Cancer Care Management
Study will enhance understanding of cancer care management due to COVID-19.
Investigators: Monique de Bruin, M.D., MPH, Su-Ying Liang, Ph.D.
Quantifying 2D and 3D MRI Imaging For Improving MS Diagnosis, Treatment, And Clinical Care
Create a longitudinal proof-of-concept MS research database (MSClinQ) that can support clinical queries, and can be updated with new tx, dx tools, care options
Investigators: Xiaowei (Sherry) Yan, PhD, MS, J.B. Jones, PhD, MBA
Improving Cancer Care
Project will provide information about referrals to palliative care and way to enhance goals of care discussions for patients diagnosed with stage IV cancer.
Investigator: Su-Ying Liang, Ph.D.
Major Depressive Disorder
Purpose is to use EHR to understand the management of major depressive disorder in a large healthcare system, to incorporate pt-reported data in care workflow.
Investigator: Kristen M.J. Azar, R.N., BSN, MSN/MPH
Using Mobile Technology and Analytics to Track Outcomes in MS Patients
Develop an app to collect and transform pt-reported outcomes in MS for health care providers to improve care and support shared decision making.
Investigators: Xiaowei (Sherry) Yan, PhD, MS, J.B. Jones, PhD, MBA
Transforming Primary and Specialty Care for Inflammatory Bowel Disease
Use healthcare data to personalize the healthcare experience for people with inflammatory bowel disease.
Implementing Universal Lynch Syndrome Screening Across Multiple Healthcare Systems: Identifying Strategies to Facilitate and Maintain Programs in Different Organizations Contexts
To describe and explain variations in Lynch syndrome (LS) screening implementation across healthcare systems and create a toolkit for implementing LS screening.
Investigators: Monique de Bruin, M.D., MPH, Su-Ying Liang, Ph.D., External PI, Principal Investigator
Lung Function Improvement After Bronchoscopic Lung Volume Reduction With Pulmonx Endobronchial Valves Used in Treatment of Emphysema (LIBERATE)
This study investigates the safety and effectiveness of the Pulmonx EBV for treating emphysema symptoms as compared to a standard medical therapy alone.
Investigator: Ganesh Krishna, M.D.